Good morning :)
Switch to
Place Order

Unichem Laboratories Ltd

UNICHEMLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,350 cr, stock is ranked 648
Moderate RiskStock is 2.59x as volatile as Nifty
333.901.55 (-0.46%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,350 cr, stock is ranked 648
Moderate RiskStock is 2.59x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
68.48
PB RatioPB Ratio
0.92
Dividend YieldDiv. Yield
1.20%
Sector PESector PE
40.61
Sector PBSector PB
5.75
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020213.551.281.201.292.54-0.02-0.060.03
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnJul 10, 2021

Unichem Laboratories Limited has informed the Exchange regarding a press release dated July 10, 2021, titled "Press Release pertaining to receipt of Tentative Approval for ANDA from United States Food and Drug Administration (USFDA) ". | Download

Unichem Laboratories Limited has informed the Exchange regarding a press release dated July 10, 2021, titled "Press Release pertaining to receipt of Tentative Approval for ANDA from United States Food and Drug Administration (USFDA) ". | Download

Updates 
Announced OnJul 7, 2021

Unichem Laboratories Limited has informed the Exchange regarding 'Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2021.'. | Download

Unichem Laboratories Limited has informed the Exchange regarding 'Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2021.'. | Download

Cash Dividend 
Ex. DateJul 22, 2021

Final • Div/Share: ₹ 4

See all events